FDA relaxes controversial restrictions on access to abortion pill by mail
The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.
Stay updated with breaking news from Devos Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.
Updated December 16, 2021 at 5:08 PM ET The Food and Drug Administration has announced it will relax controversial restrictions on a heavily regulated
Baltimore Archbishop William E. Lori decried the FDA’s decision to no longer require the abortion drug mifepristone to be picked up in person.
WASHINGTON—The Food and Drug Administration (FDA) today significantly weakened longstanding safety protocols for dangerous chemical abortion pills that have been in place for more than 20 years. Melanie Israel, policy analyst in Heritage’s DeVos Center for Religion and Civil Society, released the following statement Thursday on the implications of this action:
The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.